Venous Thromboembolism Prophylaxis in Gynecological Oncology: The review of guidelines

  • سال انتشار: 1402
  • محل انتشار: مجله تحقیقات سرطان، دوره: 8، شماره: 1
  • کد COI اختصاصی: JR_MCIJO-8-1_001
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 65
دانلود فایل این مقاله

نویسندگان

Berrak Mermit Erçek

Department of Medical Oncology, Faculty of Medicine, Van Yuzuncu Yıl University, Van, Turkey

Buket Mermit

Department of Pulmunology, Faculty of Medicine, Van Yuzuncu Yıl University, Van, Turkey

Erbil Karaman

Department of Gynecological Oncology, Faculty of Medicine, Van Yuzuncu Yıl University, Van, Turkey

چکیده

Venous thromboembolism (VTE) is one of the leading causes of death in cancer patients. VTE prophylaxis and/or treatment in the treatment and follow-up of cancer patients will reduce mortality and morbidity rates. Although the incidence of VTE in cancer patients is high, there is not yet a standardized protocol for the prevention of VTE in the subgroup of gynecological cancer patients. VTE prophylaxis and treatment vary according to the cancer type of the patients and the treatment approaches to be applied. In this review, it is aimed to explain the pathogenesis, risk factors and treatment approaches in VTE prophylaxis in gynecological oncology patients, taking into account international consensus reports. All reviewed guidelines recommended VTE prophylaxis for all hospitalized patients with active cancer. All guidelines agree that low molecular weight heparin (LMWH) gives good results in VTE prophylaxis in patients diagnosed with gynecological cancer. Risk scoring has been recommended for outpatients after discharge, and current guidelines recommend direct oral anticoagulants (DOAC) for the prevention of VTE in high-risk patients. Due to the high risk of bleeding in the gynecological cancer patient population, the side effects of pharmacological agents should be well considered and more attention should be paid to mechanical prophylactic methods.

کلیدواژه ها

Venous Thromboembolism, Gynecologic Neoplasm, Anticoagulants

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.